Lilly Raises Sales Outlook by $5.5 Billion, Cuts EPS Forecast
Eli Lilly reported third-quarter non-GAAP EPS of $7.48 versus analysts’ consensus of $5.68 and revenue of $24.4 billion versus $22.58 billion. Revenue rose 39%, with volume up 53% and realized prices down 15%.
Story updates
03:41:34 PM UTC
SquawkNews
Eli Lilly reported third-quarter 2026 revenue of $24.4 billion, up 38.6% from the prior-year quarter, while net income rose 15.5% to $6.45 billion and diluted EPS increased 16.3% to $7.22. Revenue growth reflected higher volume, partly offset by lower realized prices.Financial Highlights¹ Reported…
Eli Lilly NYSE:LLY shares rose 7.52% as of 10:00 a.m. ET after the company reported third-quarter non-GAAP EPS of $7.48, above the analysts' consensus of $5.68, on revenue of $24.4 billion, ahead of the $22.58 billion estimate.Revenue rose 39%, as volume grew 53% while realized prices fell 15%. Mou…